Depósito Digital de Documentos de la UAB Encontrados 38 registros  1 - 10siguientefinal  ir al registro: La búsqueda tardó 0.02 segundos. 
1.
11 p, 2.4 MB Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide / Martinez-Sanchez, Julia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hamelmann, H. (Department of Hematology and Oncology. Berlin Institute of Health) ; Palomo, Marta (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mir, Enrique (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Moreno-Castaño, A.B. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Torramade, S. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Rovira, M. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Escolar, G. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cordes, S. (Department of Hematology and Oncology. Berlin Institute of Health) ; Kalupa, M. (Department of Hematology and Oncology. Berlin Institute of Health) ; Mertlitz, S. (Department of Hematology and Oncology. Berlin Institute of Health) ; Riesner, K. (Department of Hematology and Oncology. Berlin Institute of Health) ; Carreras, E. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Penack, O. (Department of Hematology and Oncology. Berlin Institute of Health) ; Díaz-Ricart, Maribel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Angiogenesis and endothelial activation and dysfunction have been associated with acute graft-vs. -host disease (aGVHD), pointing to the endothelium as a potential target for pharmacological intervention. [...]
2019 - 10.3389/fimmu.2019.02339
Frontiers in immunology, Vol. 10 (september 2019) , p. 2339  
2.
9 p, 742.8 KB The Genome in a Three-Dimensional Context : Deciphering the Contribution of Noncoding Mutations at Enhancers to Blood Cancer / Rovirosa Mulet, Llorenç (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ramos-Morales, Alberto (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Javierre, BM (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Associations between blood cancer and genetic predisposition, including both inherited variants and acquired mutations and epimutations, have been well characterized. However, the majority of these variants affect noncoding regions, making their mechanisms difficult to hypothesize and hindering the translation of these insights into patient benefits. [...]
2020 - 10.3389/fimmu.2020.592087
Frontiers in immunology, Vol. 11 (july 2020) , p. 592087  
3.
13 p, 1.1 MB Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor : Experience from an academic phase i clinical trial / Castella, M. (Blood and Tissue Bank BST) ; Caballero-Baños, M. (Hospital Sant Joan de Déu) ; Ortiz-Maldonado, V. (Hospital Clínic i Provincial de Barcelona) ; González-Navarro, E.A. (Hospital Clínic i Provincial de Barcelona) ; Suñé, G. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Antoñana-Vidósola, A. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Boronat, A. (Hospital Clínic i Provincial de Barcelona) ; Marzal, B. (Hospital Clínic i Provincial de Barcelona) ; Millán, L. (Hospital Clínic i Provincial de Barcelona) ; Martín-Antonio, B. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cid, J. (Hospital Clínic i Provincial de Barcelona) ; Lozano, M. (Hospital Clínic i Provincial de Barcelona) ; García, E. (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Tabera, J. (Hospital Clínic i Provincial de Barcelona) ; Trias, E. (Hospital Clínic i Provincial de Barcelona) ; Perpiña, U. (Universitat de Barcelona. Departament de Ciències Biomèdiques) ; Canals, J.M. (Universitat de Barcelona) ; Baumann, T. (Hospital Clínic i Provincial de Barcelona) ; Benítez-Ribas, D. (Hospital Clínic i Provincial de Barcelona) ; Campo, E. (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Yagüe, J. (Universitat de Barcelona) ; Urbano Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rives, S. (Institut de Recerca Sant Joan de Déu) ; Delgado, J. (Centro de Investigación Biomédica en Red de Cáncer) ; Juan, M. (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Development of semi-automated devices that can reduce the hands-on time and standardize the production of clinical-grade CAR T-cells, such as CliniMACS Prodigy from Miltenyi, is key to facilitate the development of CAR T-cell therapies, especially in academic institutions. [...]
2020 - 10.3389/fimmu.2020.00482
Frontiers in immunology, Vol. 11 (2020) , p. 482  
4.
11 p, 2.0 MB Ethyl Pyruvate Induces Tolerogenic Dendritic Cells / Djedovic, Neda (University of Belgrade. Department of Immunology) ; Mansilla, María José (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Jevtić, Bojan (University of Belgrade. Department of Immunology) ; Navarro-Barriuso, Juan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Saksida, Tamara (University of Belgrade. Department of Immunology) ; Martínez-Cáceres, Eva M. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Miljković, Ðorđe (University of Belgrade. Department of Immunology)
Dendritic cells (DC) are professional antigen presenting cells that have a key role in shaping the immune response. Tolerogenic DC (tolDC) have immuno-regulatory properties and they are a promising prospective therapy for multiple sclerosis and other autoimmune diseases. [...]
2019 - 10.3389/fimmu.2019.00157
Frontiers in immunology, Vol. 10 (February 2019) , art. 157  
5.
1.4 MB FHLdb : A Comprehensive Database on the Molecular Basis of Familial Hemophagocytic Lymphohistiocytosis / Viñas-Giménez, Laura (Jeffrey Model Foundation Excellence Center) ; Padilla Sirera, Natàlia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Batlle-Masó, Laura (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Casals, Ferran (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Rivière, Jacques G. (Jeffrey Model Foundation Excellence Center) ; Martínez-Gallo, Mónica (Jeffrey Model Foundation Excellence Center) ; de la Cruz, Xavier (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Colobrán Oriol, Roger (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Background: Primary immunodeficiencies (PIDs) are a heterogeneous group of disorders. The lack of comprehensive disease-specific mutation databases may hinder or delay classification of the genetic variants found in samples from these patients. [...]
2020 - 10.3389/fimmu.2020.00107
Frontiers in immunology, Vol. 11 (january 2020)  
6.
11 p, 879.8 KB Pertussis prevention : Reasons for resurgence, and differences in the current acellular pertussis vaccines / Esposito, S. (Department of Surgical and Biomedical Sciences. Paediatric Clinic. Università degli Studi di Perugia) ; Stefanelli, P. (Department of Infectious Diseases. Istituto Superiore di Sanità) ; Fry, N.K. (Immunisation and Countermeasures Division. Public Health England-National Infection Service) ; Fedele, G. (Department of Infectious Diseases. Istituto Superiore di Sanità) ; He, Q. (Department of Medical Microbiology. Capital Medical University) ; Paterson, P. (Department of Infectious Disease Epidemiology. Vaccine Confidence Project TM. London School of Hygiene and Tropical Medicine) ; Tan, T. (Division of Pediatric Infectious Diseases. Department of Pediatrics. Northwestern University. Feinberg School of Medicine. Ann and Robert H. Lurie Children's Hospital of Chicago) ; Knuf, M. (Department of Pediatrics. University Medicine) ; Rodrigo Gonzalo de Líria, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Olivier, C.W. (Retired) ; Flanagan, K.L. (Department of Immunology and Pathology. Monash University) ; Hung, I. (Department of Medicine. LKS Faculty of Medicine. University of Hong Kong) ; Lutsar, I. (Department of Microbiology. Institute of Biomedicine and Translational Medicine. University of Tartu) ; Edwards, K. (Division of Pediatric Infectious Diseases. Department of Pediatrics. Vanderbilt University School of Medicine) ; O'Ryan, M. (Microbiology and Mycology Program. Faculty of Medicine. Institute of Immunology and Immunotherapy. University of Chile) ; Principi, N. (Retired) ; Universitat Autònoma de Barcelona
Pertussis is an acute respiratory disease caused by Bordetella pertussis. Due to its frequency and severity, prevention of pertussis has been considered an important public health issue for many years. [...]
2019 - 10.3389/fimmu.2019.01344
Frontiers in immunology, Vol. 10 Núm. JUL (2019) , p. 1344  
7.
12 p, 1.3 MB Regulation of TSHR expression in the thyroid and thymus may contribute to TSHR tolerance failure in graves' disease patients via two distinct mechanisms / Marín-Sánchez, Ana María (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Álvarez de la Sierra, Daniel (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; González, Oscar (Hospital Universitari Vall d'Hebron) ; Lucas-Martin, Ana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sellés-Sánchez, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rudilla, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Enrich, Emma (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colobrán Oriol, Roger (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Pujol-Borrell, Ricardo (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Graves' disease (GD) involves the presence of agonistic auto-antibodies against the thyrotropin receptor (TSHR), which are responsible for the clinical symptoms. While failure of TSHR tolerance is central to GD pathogenesis, the process leading to this failure remains poorly understood. [...]
2019 - 10.3389/fimmu.2019.01695
Frontiers in immunology, Vol. 10 (July 2019) , art. 1695  
8.
First universal newborn screening program for severe combined immunodeficiency in europe. Two-years' experience in catalonia (Spain) / Argudo-Ramírez, A. (Hospital Clínic i Provincial de Barcelona) ; Martín-Nalda, A. (Hospital Universitari Vall d'Hebron) ; Marín-Soria, J.L. (Hospital Clínic i Provincial de Barcelona) ; López-Galera, R.M. (Hospital Clínic i Provincial de Barcelona) ; Pajares-García, S. (Hospital Clínic i Provincial de Barcelona) ; de Aledo-Castillo, J.M.G. (Hospital Clínic i Provincial de Barcelona) ; Martínez-Gallo, M. (Hospital Universitari Vall d'Hebron) ; García-Prat, M. (Hospital Universitari Vall d'Hebron) ; Colobrán Oriol, Roger (Hospital Universitari Vall d'Hebron) ; Riviere, J.G. (Hospital Universitari Vall d'Hebron) ; Quintero, Y. (Hospital Clínic i Provincial de Barcelona) ; Collado, T. (Hospital Clínic i Provincial de Barcelona) ; García-Villoria, J. (Hospital Clínic i Provincial de Barcelona) ; Ribes, A. (Hospital Clínic i Provincial de Barcelona) ; Soler-Palacín, P. (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Severe combined immunodeficiency (SCID), the most severe form of T-cell immunodeficiency, can be screened at birth by quantifying T-cell receptor excision circles (TRECs) in dried blood spot (DBS) samples. [...]
2019 - 10.3389/fimmu.2019.02406
Frontiers in immunology, Vol. 10 Núm. OCT (2019), p. 2406
   
9.
12 p, 3.3 MB Adaptive Features of Natural Killer Cells in Multiple Sclerosis / Moreira Villanueva, Antía (Institut Hospital del Mar d'Investigacions Mèdiques) ; Alari-Pahissa, Elvira (Universitat Pompeu Fabra) ; Munteis, Elvira (Institut Hospital del Mar d'Investigacions Mèdiques) ; Vera, Andrea (Institut Hospital del Mar d'Investigacions Mèdiques) ; Zabalza, Ana (Institut Hospital del Mar d'Investigacions Mèdiques) ; Llop, Mireia (Institut Hospital del Mar d'Investigacions Mèdiques) ; Villarrubia, Noelia (Hospital Universitario Ramón y Cajal (Madrid)) ; Costa-García, Marcel (Universitat Pompeu Fabra) ; Álvarez-Lafuente, Roberto (Hospital Clínico San Carlos (Madrid)) ; Villar, Luisa Maria (Hospital Universitario Ramón y Cajal (Madrid)) ; López-Botet, Miguel (Institut Hospital del Mar d'Investigacions Mèdiques) ; Martínez-Rodríguez, José E. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Universitat Autònoma de Barcelona
Human cytomegalovirus (HCMV) has been recently related with a lower susceptibility to multiple sclerosis (MS). HCMV promotes an adaptive development of NK cells bearing the CD94/NKG2C receptor with a characteristic phenotypic and functional profile. [...]
2019 - 10.3389/fimmu.2019.02403
Frontiers in immunology, Vol. 10 (15 2019) , p. 2403  
10.
5 p, 1.1 MB Caveats and pitfalls of SOX1 autoantibody testing with a commercial line blot assay in paraneoplastic neurological investigations / Ruiz-García, R. (Institut d'Investigació Biomèdica de Bellvitge) ; Martínez-Hernández, E. (Hospital Clínic i Provincial de Barcelona) ; García-Ormaechea, M. (Institut d'Investigació Biomèdica de Bellvitge) ; Español-Rego, M. (Institut d'Investigació Biomèdica de Bellvitge) ; Sabater, L. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Illa, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Dalmau, J. (Department of Neurology. University of Pennsylvania) ; Graus Ribas, Francesc (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Universitat Autònoma de Barcelona
SOX1 autoantibodies are considered markers of small cell lung cancer (SCLC) and paraneoplastic neurological syndromes (PNS) and are usually determined by commercial line blot in many clinical services. [...]
2019 - 10.3389/fimmu.2019.00769
Frontiers in immunology, Vol. 10 Núm. APR (2019) , p. 769  

Depósito Digital de Documentos de la UAB : Encontrados 38 registros   1 - 10siguientefinal  ir al registro:
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.